Last reviewed · How we verify

NCT06223620

A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction

Completed Last updated 24 March 2026
What this trial tests

trial testing review performance of water soluble contrast in SBO - Small Bowel Obstruction in 504 participants. Completed in 31 December 2019.

Timeline
30 July 2018
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorMethodist Health System
StatusCompleted
Study typeOBSERVATIONAL
Enrollment504
Start date30 July 2018
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Methodist Health System — full company profile →

Who can join

Adults 18 to 89, any sex, with SBO - Small Bowel Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to review performance of water soluble contrast study in patients admitted with Small Bowel Obstruction(SBO), will improve quality and safety, and decrease length of stay and morbidity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Methodist Health System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06223620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing